<DOC>
	<DOCNO>NCT00277446</DOCNO>
	<brief_summary>An epidemiologic study patient asthma show increased intake soy isoflavones correlate less severe asthma . In experimental animal , treatment soy isoflavone genistein reduce airways inflammation hyper-responsiveness . In vitro study perform u show genistein reduces release inflammatory compound human blood eosinophil . The purpose pilot study determine whether dietary supplementation soy isoflavones effect patient asthma . 20 patient asthma supplement diet soy isoflavone capsule 4 week . Before supplementation period , measure lung function , exhale nitric oxide ( marker airway inflammation ) , collect exhale breath condensate measure level inflammatory mediator airway , isolate peripheral blood eosinophil assess impact soy isoflavones function . We hypothesize dietary supplementation soy isoflavones reduce exhale nitric oxide level , reduce inflammatory mediator exhale breath condensate , reduce ability eosinophil release inflammatory molecule . Identifying hypothesized effect soy isoflavones exist asthma provide justification clinical study .</brief_summary>
	<brief_title>Dietary Supplementation With Soy Isoflavones Asthma</brief_title>
	<detailed_description>This prospective pilot study conduct 20 subject asthma . The participant undergo follow procedure : 1 . Completion questionnaire ask information asthma include symptom , medication , ability participate activity . 2 . Measurement exhale nitric oxide ( NO ) subject breathe slowly tube . This test take 5 minute . 3 . Collection air exhale lung condense liquid form . This call exhaled breath condensate . This procedure involve breathe slow tube period 15 minute . The measurement determine method exclusively research purpose use routine clinical setting . 4 . Measurement lung function spirometer . This involve breathe forcefully mouthpiece . 5 . Collection 60 ml ( 4 tablespoon ) blood measure genistein ( major component soy isoflavone ) level eosinophil function . These measurement also research purpose routinely use clinically . Each measurement make 4 week period dietary supplementation soy isoflavones .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>Ages 1850 , male female Physician diagnosis asthma ; require daily asthma medication Moderate persistent disease ( NAEPP guideline ) FEV1 65 90 % predict At least 12 % increase FEV1 1530 minute inhale 24 puff albuterol positive methacholine challenge ( 20 % fall FEV1 le 8 mg/ml ) either available previous 2 year Generally good health Oral corticosteroid use within past 3 month Use high dose inhale corticosteroid ( great 500 mcg fluticasone per day great ) Current former smoker ( quit less 6 month prior study enrollment great 10 pack year ) Recent asthma exacerbation ( within 6 week ) Current consumption soy isoflavone supplement Known adverse reaction genistein , phytoestrogens , soy product Pregnant Unintentional weight loss 10 pound within year Major unstable medical condition Use investigational drug previous 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Soy isoflavones</keyword>
	<keyword>Eosinophils</keyword>
	<keyword>Exhaled nitric oxide</keyword>
</DOC>